Quantinno Capital Management LP Buys 26,418 Shares of Astrana Health, Inc. $ASTH

Quantinno Capital Management LP grew its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 69.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,509 shares of the company’s stock after purchasing an additional 26,418 shares during the period. Quantinno Capital Management LP owned approximately 0.12% of Astrana Health worth $1,582,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Royal Bank of Canada grew its stake in shares of Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after buying an additional 17,028 shares during the period. AQR Capital Management LLC acquired a new position in Astrana Health during the 1st quarter worth approximately $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after buying an additional 1,263 shares during the period. Jones Financial Companies Lllp boosted its holdings in Astrana Health by 4,365.2% in the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after acquiring an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC boosted its holdings in Astrana Health by 5.8% in the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock worth $1,383,000 after acquiring an additional 2,462 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Wall Street Analysts Forecast Growth

ASTH has been the subject of several recent research reports. Robert W. Baird set a $45.00 price objective on Astrana Health in a report on Friday, May 8th. Barclays increased their target price on Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Weiss Ratings raised shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 1st. TD Cowen boosted their price target on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Wall Street Zen upgraded shares of Astrana Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $49.43.

Astrana Health Stock Performance

Shares of ASTH opened at $35.79 on Thursday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.35 and a current ratio of 1.23. The stock has a 50 day moving average price of $41.29 and a two-hundred day moving average price of $32.70. The firm has a market capitalization of $1.99 billion, a P/E ratio of 43.65 and a beta of 0.87. Astrana Health, Inc. has a 52 week low of $18.08 and a 52 week high of $51.60.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.